NCT00069017已完成2 期
A Phase II, Randomized, Double-Blind Study to Evaluate the Effects of MEDI-522, a Humanized MAb to Integrin Alpha V Beta 3, On Disease Activity and Progression of Joint Damage in Pts With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 80
研究概览
简要总结
To compare, as a preliminary analysis, the effects of MEDI-522 versus placebo at 6 months on disease activity (ACR20) and progression of structural joint damage.
详细描述
To compare, as a preliminary analysis, the effects of subcutaneously administered MEDI-522 versus placebo at 6 months on disease activity and progression of structural joint damage in patients with rheumatoid arthritis (RA), who have active disease despite ongoing treatment with methotrexate (MTX) with or without hydroxychloroquine (HCQ) and/or sulfasalazine (SSZ).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (80)
Loading locations...
相似试验
已完成
2 期
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus ErythematosusSystemic Lupus ErythematosusNCT01438489MedImmune LLC626
已完成
2 期
A Study of ARRY-502 in Patients With Persistent AsthmaAsthmaNCT01561690Pfizer184
已完成
2 期
A Phase 2 Clinical Study of CU-20401Efficacy and SafetyNCT06194188Cutia Therapeutics（Wuxi）Co.,Ltd108
招募中
2 期
Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)Adrenocortical CarcinomaNCT05913427Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia80
已完成
2 期
A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular DiseaseMild to Moderate Dementia Due to Alzheimer's DiseaseWith or Without Coexisting Cerebrovascular DiseaseNCT03462121Regenera Pharma Ltd83